Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

DERep Home Page

["Allergy, Intolerance": "Beta Blocker Therapy Ingredient"]

Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for medications containing ingredients for beta blocker therapy.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable beta blockers.
Exclusion Criteria: No exclusions.

Constrained to codes in the Allergy, Intolerance: Beta Blocker Therapy Ingredient value set (2.16.840.1.113883.3.526.3.1493)

QDM Datatype and Definition

"Allergy Intolerance"

Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.

Timing:

  • The prevalence period references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
  • The author dateTime references the recorded time.
eCQMs using this data element:
CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
QDM Attributes

prevalencePeriod

Prevalance Period is the time from onset dateTime to abatement dateTime.
Last Updated: Jul 08, 2021

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.